Français
ItalianoBond Gilead Sciences 5.65% ( US375558AS26 ) in USD
| Issuer | Gilead Sciences | ||||||||||||||||||||||||||||||||
| Market price |  101.09 % ▼ |
||||||||||||||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||||||||||||||
| ISIN code |
 US375558AS26 ( in USD )
|
||||||||||||||||||||||||||||||||
| Interest rate | 5.65% per year ( payment 2 times a year) | ||||||||||||||||||||||||||||||||
| Maturity | 01/12/2041 | ||||||||||||||||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||||||||||||||
| Total amount | 1 000 000 000 USD | ||||||||||||||||||||||||||||||||
| Cusip | 375558AS2 | ||||||||||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||
| Next Coupon | 01/12/2026 ( In 97 days ) | ||||||||||||||||||||||||||||||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558AS26, pays a coupon of 5.65% per year. The coupons are paid 2 times per year and the Bond maturity is 01/12/2041 The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558AS26, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558AS26, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||